Telzuit Announces New Patent Filing for Monitoring
Device for Nursing Home / Assisted Living Facility Patients
ORLANDO, Fla. 2005 -- Telzuit Medical Technologies, Inc.has announced
that the Company has filed for provisional patents with the US
Patent & Trademark Office for a new monitoring device utilizing
the Company's BioPatch platform. The new device, developed by
the Company's Senior Vice President of Product Development, Michael
Vosch, is intended for use in nursing homes and assisted living
facilities. The Company expects to have all of the necessary modifications
made to its production model within a short period of time and
be able to market the new product in 2006. In addition to providing
basic biometric data on patients, the Company anticipates that
it will also be able to detect if a patient has fallen. Once fully
developed, by utilizing the BioPatch platform, the patient's data
can be relayed to either a PDA or a PC enabling caregivers to
monitor more patients with better efficiency.
Donald Sproat, CEO and President of Telzuit Medical Technologies,
Inc. said, "Those of us with the Company are very excited
about the possibility that our new technology will be available
for use by assisted living and nursing home patients in 2006.
With over 1.8 million nursing home beds and over 1.2 million assisted
living facility beds already in existence in the United States,
we expect our new device to have a real impact on the quality
of care in each of these instances as we provide better tools
for health care providers to use."
Telzuit's revolutionary heart monitoring system will combine,
for the first time, an entirely wireless 12-lead EKG with 24-hour
near real-time monitoring. The device replaces old technology
in both Cardiac Holter Monitoring and Cardiac Event Monitoring
by providing the patient with a reliable alternative to what is
in the market currently, as well as providing the physician with
more data than he/she would receive using those same devices.
This is a state-of-the-art system that will provide physicians
with the latest in mobile monitoring technology and security.
About Telzuit Medical Technologies, Inc.
Telzuit Medical Technologies, Inc. and its wholly owned subsidiary
Telzuit Technologies, Inc. are dedicated to providing advanced
mobile medicine for people worldwide. The first step in this mission
will initially take the form of our state-of-the-art, FDA approved,
Bio-Patch Wireless Heart Monitor. This is a full 12-lead, completely
wireless, Holter monitor, which is new to the marketplace. Telzuit
anticipates that the product will be available to patients and
physicians during the 2005 calendar year.
Telzuit is also building its own dedicated intranet as a platform
to handle several of the products it will be releasing, including
its initial product, the Bio-Patch Wireless Heart Monitor. More
information on Telzuit can be found on its website.